Director, Global Value, Access & Pricing, Solid Tumors & Pipeline

BeOne continues to grow at a rapid pace with challenging and exciting opportunities for experienced professionals. When considering candidates, we look for scientific and business professionals who are highly motivated, collaborative, and most importantly, share our passionate interest in fighting cancer. General Description: The position will report directly to the Executive Director (ED), Global Value, Access & Pricing (GVAP), Solid Tumors (ST) Lead, and will be responsible for developing GVAP strategies across the Solid Tumor portfolio for pipeline assets, under the direct supervision and approval of the ED, GVAP, Lead, Solid Tumors. For the purposes of this role, a “pipeline asset” is any internally developed or externally acquired or licensed asset for which no Company Leadership endorsement for making the first major regulatory filing has occurred. The ED, GVAP Solid Tumors, in alignment with the VP, Global Head of GVAP, retains the authority to define and modify the scope of what constitutes a pipeline asset. Under the above definition, an asset will remain a “pipeline asset” until approximately 6-9 months before the first regulatory filing, at which time the Director, GVAP, Solid Tumors Pipeline transitions the asset to the Director, GVAP, Solid Tumors In-line. Subsequent indications or line extensions of the asset would be the on-going responsibility of Director, GVAP, Solid Tumors In-line. Notwithstanding the above, the ED, GVAP, Lead Solid Tumors, retains the discretion to assign to the Director, GVAP, Solid Tumors Pipeline responsibilities that would otherwise fall to the Director, GVAP, Solid Tumors In-line, based on the evolving needs of the organization. The Director, GVAP, Solid Tumors Pipeline provides critical strategic insights and guidance to ensure pipeline assets meet future market access needs and maximize commercial potential. The person in this position will focus on identifying market access-related evidentiary gaps in clinical development plans that could result in a breadth of reimbursement inconsistent with planned labelled population(s) and/or pricing that does not sustainably support the business. The person in this role will work cross-functionally with relevant stakeholders to develop recommendations to close those gaps and/or for evidence generation that, if implemented, would result in optimizing reimbursement and pricing potential. The person in this role must be capable of estimating the impact of different clinical development scenarios on access and price potential. The person in this role will confer with the ED, GVAP, Lead Solid Tumors, to determine how and when to disseminate GVAP analysis and recommendations. Furthermore, the position will support portfolio prioritization exercises. This is a senior role that is critical in setting the foundation for the Company’s future Solid Tumor (ST) product success in that the person in this role develops a strategic vision for the pipeline, which is informed by market access expertise and a deep understanding of the evolving needs of global payers. Location: East Coast (EST) location is heavily preferred. Essential Functions of the job: Pipeline Market Access Strategy Development: • Lead the creation and implementation of global pricing and market access strategies for ST pipeline products (typically but not exclusively Phase II and III assets), aligning with clinical and commercial goals. • Collaborate cross-functionally to integrate access requirements into the development process, influencing trial design, endpoints, and evidence generation to meet payer needs. • Lead the collection and aggregation of feedback from all regions in which the Company operates and develop recommendations regarding clinical development and other evidence generation based on that feedback. • In alignment with the ED, GVAP ST, represent the GVAP ST perspective (aligned with Regions and/or focus markets and HEOR) to governance or oversight bodies of the Company (e.g., GPT, GBT) Value Proposition & Evidence Generation: • Develop early value propositions that resonate with global payers and support future pricing, reimbursement, and access decisions. • Work closely with Clinical, Medical Affairs, and Health Economics & Outcomes Research (HEOR) teams to shape clinical trial design and evidence-generation strategies that align with target market access requirements. • Identify and prioritize evidence gaps; work closely with HEOR to ensure development of health economic models, burden-of-illness studies, and other data to address payer concerns and enhance product differentiation. Cross-Functional Collaboration & Stakeholder Engagement: • If delegated by ED, GVAP ST, serve as the primary market access point of contact for one or more GPTs. • Collaborate with R&D, Commercial (incl. PSV), Medical Affairs, and Regulatory Affairs to ensure access-related insights and payer needs are integrated into the overall development strategy. • Provide input into clinical decisions and Business Development to ensure payer requirements are recognized, addressed and or additional evidence generated through other means, in support of the commercial strategy development expectations, trends and risks. • Engage with focus markets and regional access teams to ensure early alignment on access strategies and support local adaptation for specific market needs. • Working together with commercial, clinical, medical / HEOR and regional market access teams, align on early asset target product profile definitions and evidence required as well as planned value proposition that will support value positioning and reduce pricing and reimbursement uncertainties across all regions in which BeiGene operates. Pre-Launch Preparation: • Drive pre-launch planning for pipeline products, including the creation of early value toolkits and JCA relevant PICOs and early engagement strategies to optimize future access and reimbursement. • Support market access launch readiness through regular communication, training, and support to regional and affiliate teams, preparing them to engage with payers as the product nears market entry. • Support regional activities relating to regional asset in-licensing for early pipeline products. Market Insights & Competitive Landscape Analysis: • Continuously monitor the solid tumor landscape, including competitor activities, evolving payer requirements, and regulatory changes that impact access and reimbursement. • Run analysis of payer insights, pricing trends, and market conditions to inform strategy adjustments and refine access plans. • Use global and regional insights to refine value propositions and enhance product positioning as the product advances through clinical phases. • Lead early pipeline consultation processes with payers across all regions (in collaboration with the regions and/or focus markets) (e.g., CADTH, NICE, etc.). Supervisory Responsibilities: •N/A Qualifications: •BA/BS Degree with 10 years of related pharmaceutical experience is necessary with at least 5 years of direct experience in global/ regional or local Market Access functions. Experience from pipeline/early development and JCA preparation a strong advantage. • Deep experience in market access and payer engagement within the oncology therapeutic area, with a strong ability to develop and deliver value toolkits that support regional and affiliate teams. • Detailed understanding of global pricing & reimbursement landscape, including the interrelatio